Cargando…
Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series
BACKGROUND: Patients with advanced and/or metastatic solid tumors have limited treatment options. Mutations that serve as biomarkers of carcinogenesis can be found in cell-free DNA of patients’ plasma. Analysis of circulating tumor DNA (ctDNA) was developed as a non-invasive, cost-effective alternat...
Autores principales: | Naqvi, Mohammad Faraz, Vo, Henry Hiep, Vining, David, Tsimberidou, Apostolia-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107674/ https://www.ncbi.nlm.nih.gov/pubmed/33995588 http://dx.doi.org/10.1177/17588359211001538 |
Ejemplares similares
-
Clinical trial design in the era of precision medicine
por: Fountzilas, Elena, et al.
Publicado: (2022) -
Dataset of phase I and II immunotherapy clinical trials used for a meta-analysis to assess the role of biomarkers in treatment outcomes in diverse cancers
por: Fountzilas, Elena, et al.
Publicado: (2023) -
Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center
por: Vo, Henry Hiep, et al.
Publicado: (2022) -
First-in-Human Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors
por: Tsimberidou, Apostolia Maria, et al.
Publicado: (2023) -
Prolonged hyperglycemia in three patients with type 2 diabetes after COVID-19 infection: A case series
por: Downes, Jessica M., et al.
Publicado: (2021)